R 534 (Divalproex sodium extended-release 500 mg)
Pill imprint R 534 has been identified as Divalproex sodium extended-release 500 mg.
Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- R 534
- Strength:
- 500 mg
- Color:
- Gray
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Fatty acid derivative anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine - CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Dr. Reddy's Laboratories Ltd.
More about divalproex sodium
Consumer resources
- Divalproex delayed-release tablets
- Divalproex extended-release tablets
- Divalproex sprinkle capsules
- Divalproex sodium
- Divalproex sodium (Advanced Reading)
- Other brands: Depakote, Depakote ER, Depakote Sprinkles
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
